Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
479
Employees479
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
479
Employees479

REPL Key Statistics

Market cap
640.76M
Market cap640.76M
Price-Earnings ratio
-2.16
Price-Earnings ratio-2.16
Dividend yield
Dividend yield
Average volume
1.17M
Average volume1.17M
High today
$7.80
High today$7.80
Low today
$6.89
Low today$6.89
Open price
$7.12
Open price$7.12
Volume
1.68M
Volume1.68M
52 Week high
$14.80
52 Week high$14.80
52 Week low
$2.68
52 Week low$2.68

Stock Snapshot

Replimune(REPL) stock is priced at $7.75, giving the company a market capitalization of 640.76M. It carries a P/E multiple of -2.16.

On 2026-02-08, Replimune(REPL) stock traded between a low of $6.89 and a high of $7.80. Shares are currently priced at $7.75, which is +12.5% above the low and -0.6% below the high.

Replimune(REPL) shares are trading with a volume of 1.68M, against a daily average of 1.17M.

In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.

In the last year, Replimune(REPL) shares hit a 52-week high of $14.80 and a 52-week low of $2.68.

REPL News

TipRanks 5d
Replimune amends Hercules loan, strengthens funding runway

Replimune Group ( (REPL) ) has provided an update. On January 29, 2026, Replimune Group amended its loan and security agreement with Hercules Capital, extendin...

TipRanks 5d
Replimune reports Q3 EPS (77c), consensus (82c)

“We have been engaged with the FDA in the review of the BLA resubmission for RP1,” said Sushil Patel, Ph.D., CEO of Replimune (REPL). “Advanced melanoma patient...

Analyst ratings

75%

of 8 ratings
Buy
75%
Hold
25%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.